Article Versions Notes

McAllister M, Flanagan T, Cole S, Abend A, Kotzagiorgis E, Limberg J, Mead H, Mangas-Sanjuan V, Dickinson PA, Moir A, et al. Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series. Pharmaceutics. 2022; 14(5):1010. https://doi.org/10.3390/pharmaceutics14051010

McAllister, Mark, Talia Flanagan, Susan Cole, Andreas Abend, Evangelos Kotzagiorgis, Jobst Limberg, Heather Mead, Victor Mangas-Sanjuan, Paul A. Dickinson, Andrea Moir, and et al. 2022. "Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series" Pharmaceutics 14, no. 5: 1010. https://doi.org/10.3390/pharmaceutics14051010

McAllister, M., Flanagan, T., Cole, S., Abend, A., Kotzagiorgis, E., Limberg, J., Mead, H., Mangas-Sanjuan, V., Dickinson, P. A., Moir, A., Pepin, X., Zhou, D., Tistaert, C., Dokoumetzidis, A., Anand, O., Le Merdy, M., Turner, D. B., Griffin, B. T., Darwich, A., ... Mackie, C. (2022). Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series. Pharmaceutics, 14(5), 1010. https://doi.org/10.3390/pharmaceutics14051010